Industry Insights
Biosimilars: Providing More Treatment Options
Article | By Leala Thomas, Bio-Rad Laboratories, Inc.

It is hoped that the development of biosimilars will lead to more competition, and therefore, more accessible, cost-effective treatments.

Sanofi Asks: Will Standardization Take End User And Supplier Relationships To The Next Level?
Article | By Bruno Tricoire, Ph.D., Sanofi Pasteur

A larger-scale adoption of single-use technology may continue to be delayed as biopharma manufacturers must have access to a reliable supply chain that successfully delivers product to customers.

Strategic CDMO: Bringing End-To-End Solutions For Faster Drug Development
Q&A | By William E. Weiser, Patheon

Patheon's Bill Weiser discusses how a new generation of CDMOs have positioned themselves to provide strategic solutions that not only complement product development but drive therapies to patients faster.

Scalability Of Microcarrier Bead Separation Using The Harvestainer System
Application Note | Thermo Fisher Scientific

Current techniques used to separate adherent mammalian cells from microcarrier beads often use sophisticated equipment, requiring significant capital expenditure as well as routine maintenance, and cleaning and sterilization between uses.

Most Popular News
Solutions
Signals Lead Discovery
PerkinElmer, Inc.
Scientific Search: Intelligent Knowledge Management
Dassault Systèmes BIOVIA
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.